Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 876 results for "astrazeneca"

Bladder cancer clinical trial opens to patients
University of Sheffield

AstraZeneca pauses two cancer drug trials' enrolment due to bl...

AstraZeneca's high hopes for cancer immunotherapy were dented on Thursday as the recruitment of new patients with head and neck cancer into two clinical studies was put on hold, following instances of bleeding. The drugmaker said the U.S. Food and Drug ... Reuters, 9 hours ago
Bladder cancer clinical trial opens to patients University of Sheffield, 2 weeks ago

764 images for astrazeneca

Zolmax News, 12 hours ago
American Banking News, 1 day ago
Drug Discovery World, 2 days ago, 7 hours ago
Business Weekly UK, 2 days ago
Ticker Report, 2 days ago
Biz Community, 17 hours ago
Proactive Investors USA, 7 hours ago
Investor's Business Daily, 1 day ago
Biz Community, 17 hours ago

Case Study: Introducing An Automated And Validated Calibration System

The starting situation at AstraZeneca Sweden Operations was challenging and the company had many demanding requirements for a calibration system. First of all, a calibration system should save money for the company by reducing the time it takes to ...
 Pharmaceutical Online1 week ago

Withdrawn application: Zemfirza, cediranib, Initial authorisation

AstraZeneca AB officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Zemfirza, for the treatment of ovarian cancer. What is Zemfirza? Zemfirza ...
 European Medicines Agency1 week ago EMA Panel Makes Oncology Product Announcements  General Medicine eJournal1 week ago Human medicines European public assessment report (EPAR): Iressa, gefitinib, Revision: 9, Authorised  European Medicines Agency2 weeks ago
Yahoo! Finance UK and Ireland

Forget short term pain! Buy these FTSE 100 stars for long-term gain

Medical mammoth AstraZeneca (LSE: AZN) hasn't yet managed to get over the enduring hump of patent expirations, despite the bright work being achieved by its development teams. Exclusivity losses on revenue-driving labels like its Crestor ...
 Yahoo! Finance UK and Ireland1 week ago

Initiate suitable prosecution steps against AstraZeneca management, pleads FMRI

The Federation of Medical Representatives association of India has filed a dispute against the AstraZeneca for terminating employees as per the company's restructuring plan. The FMRI has filed the dispute with the state labour commissioner, ...
 Smart Investor2 weeks ago

New Findings from AstraZeneca in the Area of Drug Development Reported (Experimental and Quantum Chemical Evaluations of Pyridine Oxidation Under...

New Findings from AstraZeneca in the Area of Drug Development Reported (Experimental and Quantum Chemical Evaluations of Pyridine Oxidation Under Drug Development Stress Test Conditions) By a News Reporter-Staff News Editor at Drug Week -- Fresh ...
 4 Traders2 weeks ago Synairgen: AstraZeneca has Stopped Asthma Drug Trial  Morningstar.com2 weeks ago Synairgen shares drop as AstraZeneca stops asthma drug study  BullBearings2 weeks ago Synairgen Stock Tanks After Partner AstraZeneca PLC Halts Asthma Drug Trial  BioSpace2 weeks ago

AstraZeneca PLC Terminated 50 Sales Staff in India Last Week

MUMBAI: Trouble is brewing at British drug maker Astra-Zeneca's India unit as it terminated services of around 50 sales representatives last week as part of a global restructuring exercise and the national association of medical sales ...
 BioSpace3 weeks ago AstraZeneca medical representatives threaten strike  Business Standard3 weeks ago AstraZeneca faces protest after layoffs  Business Standard3 weeks ago AstraZeneca lays off 50 sales employees, faces protest  Business Standard3 weeks ago
Pharmaceutical Online

AstraZeneca Realizes High ROI With Infor Expense Management

Unhappy with its existing T&E systems, AstraZeneca begansearching for a solution that would better meet its needs."We wanted to accomplish several things," says Mike Herubin,manager of expense reimbursement at Astra Zeneca. "First, wewere looking to ...
 Pharmaceutical Online3 weeks ago $330M deal: AstraZeneca continues its busy week of selling  Philadelphia Business Journal2 weeks ago This stock tanked 11% in an otherwise dull market  Money Today2 months ago Top buzzing midcap stocks to trade on August 25  Money Control2 months ago

AstraZeneca: Despite Brilinta's Trial Miss, Long-Term Holds Potential

Last week, AstraZeneca's (NYSE: AZN ) blood thinning drug Brilinta failed a drug trial when it was unsuccessful in improving symptomatic peripheral artery disease patients relative to Plavix (i.e., clopidogrel), initially approved by the FDA in ...
 Seeking Alpha2 weeks ago Is It Time To Consider AstraZeneca?  Seeking Alpha2 weeks ago AstraZeneca cuts Brilinta sales hopes on artery disease failure  Reuters3 weeks ago AstraZeneca wins UK cost approval for longer use of heart drug  Reuters2 months ago

Case Study: Checkweighers Help AstraZeneca Ensure Accuracy In A Tight Spot

The Investigational Products group, part of the Pharmaceutical and Analytical R&D function located at the AstraZeneca plant in Newark, DE, has a bottle-filling line that is utilized for the packaging of clinical trials. Prior to installing the ...
 Pharmaceutical Online2 weeks ago Checkweighers Help AstraZeneca Ensure Accuracy In A Tight Spot  Pharmaceutical Online2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - astrazeneca
Get updated on latest news & your favorite topics right in your inbox!
More     Less